Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer
暂无分享,去创建一个
Moisés Blanco-Calvo | Lourdes Calvo | Angélica Figueroa | Mar Haz-Conde | Luis Antón-Aparicio | Manuel Valladares-Ayerbes | Angélica Figueroa | M. Blanco-Calvo | M. Valladares-Ayerbes | L. Calvo | L. Antón-Aparicio | Mar Haz-Conde
[1] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[2] Xinjun Zhang,et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker , 2010, Journal of Molecular Medicine.
[3] Yoshiki Murakami,et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[4] Tongyu Lin,et al. Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.
[5] T Kawaguchi,et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma , 2012, British Journal of Cancer.
[6] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[7] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[8] Megan F. Cole,et al. Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells , 2008, Cell.
[9] A. Jemal,et al. Global Cancer Statistics , 2011 .
[10] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.
[11] M. Nykter,et al. Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.
[12] Longgui Wang,et al. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.
[13] D. Kang,et al. Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.
[14] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[15] Tao Jiang,et al. Circulating microRNAs in cancer: origin, function and application , 2012, Journal of Experimental & Clinical Cancer Research.
[16] Zheng Wang,et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Boland,et al. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[18] W. Tan,et al. Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis , 2011, Molecular Carcinogenesis.
[19] Xi Chen,et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. , 2012, Clinical chemistry.
[20] H. Qian,et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. , 2012, Molecular medicine reports.
[21] Li-ping Guo,et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. , 2011, Clinical science.
[22] R. Russell,et al. Principles of MicroRNA–Target Recognition , 2005, PLoS biology.
[23] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[24] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[25] Jessica A. Weber,et al. The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.
[26] Dieter Jocham,et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. , 2010, Urologic oncology.
[27] H. S. Wolff,et al. iRun: Horizontal and Vertical Shape of a Region-Based Graph Compression , 2022, Sensors.
[28] Ann M. Killary,et al. MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.
[29] P. Qi,et al. Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection , 2011, PloS one.
[30] Yu Liang,et al. BMC Genomics , 2007 .
[31] D. Ichikawa,et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer , 2011, British Journal of Cancer.
[32] Wei Zhang,et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. , 2012, Cancer letters.
[33] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[34] Peng-jun Zhang,et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.
[35] R. Aharonov,et al. MicroRNAs accurately identify cancer tissue origin , 2008, Nature Biotechnology.
[36] Erin K Hanson,et al. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. , 2009, Analytical biochemistry.
[37] Xi Chen,et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.
[38] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[39] Xi Chen,et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.
[40] Seena K. Ajit. Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules , 2012, Sensors.
[41] X. Chen,et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.
[42] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[43] Y. Gong,et al. Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis , 2011, Digestive Diseases and Sciences.
[44] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[45] M. Albitar,et al. Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.
[46] Hermann Brenner,et al. Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review , 2007, Cancer Epidemiology Biomarkers & Prevention.
[47] Wanjun Yu,et al. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. , 2011, Biochemical and biophysical research communications.
[48] I. Mittra,et al. Nucleic acids in circulation: Are they harmful to the host? , 2012, Journal of Biosciences.
[49] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[50] Y. Gong,et al. Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.